Question · Q2 2025
Pei Jinping from SIG Securities questioned management on the growth potential of China's medical aesthetics market and So-Young's strategy for handling competition from new entrants.
Answer
Mona Qiao, Investor Relations, expressed optimism, highlighting China's low market penetration (<5%) compared to mature markets like South Korea (>20%). She stated that So-Young's competitive advantage is built on three core pillars where competitors are weaker: sustainable low-cost customer acquisition, a diversified upstream supply chain, and strong organizational competence in operating a large-scale physical network.
Ask follow-up questions
Fintool can predict
SY's earnings beat/miss a week before the call